Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion

European Journal of Haematology

Volumn 77, Issue 4, 2006, Pages 318-326

  Thielen, Caroline ^a   Herens, Christian ^a   Fassotte, Marie France ^a   Detrooz, Elisabeth ^a   Drion, Pierre ^b   Diss, Tim ^c   Boniver, Jacques ^a   De Leval, Laurence ^a,d  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CHU SART TILMAN   (Belgium)

Author keywords

B cell lines; Burkitt lymphoma; Effusion lymphoma; Epstein Barr virus; GAL 01; GAL 02

Indexed keywords

BLEOMYCIN; CD20 ANTIGEN; CD38 ANTIGEN; CD79A ANTIGEN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; PROTEIN BCL 2; PROTEIN BCL 6; VINBLASTINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CELL CULTURE; CARCINOGENIC ACTIVITY; CASE REPORT; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; EFFUSION; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOPHENOTYPING; INTESTINE TUMOR; LARGE CELL LYMPHOMA; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LYMPHOMA; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 33748356697     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00724.x     Document Type: Article

References (16)

1. MAGRATH I. The pathogenesis of Burkitt's lymphomas. Cancer Res 1990;55:133-270.
2. JAFFE ES, HARRIS NL, STEIN H, VARDIMAN JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. WHO Classification of tumours, Vol. 3. Lyon, France: IARC press, 2001.
3. BOXER LM, DANG CV. Translocations involving c-myc and c-myc function. Oncogene 2001;20:5595-5610.
4. DREXLER HG. The leukemia-lymphoma cell line. Facts book series. New York: Academic press, 2001.
5. http://www.biotech.ist.unige.it
6. de LEVAL L, VIVARIO M, DE PRIJCK B, et al. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated with EBV infection. Am J Surg Pathol 2004;28:679-686.
7. NADOR RG, CESARMAN E, CHADBURN A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Karposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
8. LAGRESLE C, BELLA C, DEFRANCE T. Phenotypic and functional heterogeneity of the IgD-B cell compartment: identification of two major tonsillar B cell subsets. Int Immunol 1993;1:1259-1268.
9. CORCIONE A, ADRUINO N, FERRETTI E, et al. Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B-lineage. Leuk Res 2006;30:365-372.
10. OKADA T, NGO VN, EKLAND EH, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002;196:65-75.
11. PAIETTA E, NEUBERG D, RICHARDS S, et al. Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. Am J Hematol 2001;66:189-196.
12. MATSUBARA K, YURA K, HIRATA T, et al. Acute lymphoblastic leukemia with coexpression of CD56 and CD57: case report. Pediatr Hematol Oncol 2004;21:677-1682.
13. PETITJEAN B, JARDIN F, JOLY B, et al. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B and T-cell phenotype. Am J Surg Pathol 2002;26:724-732.
14. DE KROON JFEM, KLUIN PM, KLUIN-NELERMANS HC, WILLEMZE R, FALKENBURG FJH. Homing and antigenic characterisation of a human non-Hodgkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice. Leukemia 1994;8:1385-1391.
15. ABE M, SUZUKI O, TASAKI K, ABE R, WAKASA H. Establishment and characterisation of new human Burkitt's lymphoma cell lines (HBL-7 and HBL-8) that are highly metastatic in SCID mice: a metastatic SCID mouse model of human lymphoma lines. Pathol Int 1996;46:630-638.
16. SHAFFER AL, LIN KI, KUO TC, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002;17:51-62.